Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merit Medical Sys (MMSI)

Merit Medical Sys (MMSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
DexCom Introduces Registry to Monitor Outcomes of G6 System

DexCom (DXCM) sets up registry to track outcomes of patients and healthcare professionals using CGM in hospitals.

DXCM : 387.06 (-0.58%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
AVNS : 32.99 (-2.54%)
Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
NXGN : 12.50 (-4.36%)
Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Investor confidence is high on Allscripts (MDRX) stock, thanks to solid prospects.

MDRX : 7.84 (-3.92%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Uptrend Call Working As Merit Medical Stock Rises 32.9% (MMSI)

SmarTrend identified an Uptrend for Merit Medical (NASDAQ:MMSI) on March 26th, 2020 at $34.23. In approximately 6 months, Merit Medical has returned 32.91% as of today's recent price of $45.49.

MMSI : 40.55 (-3.89%)
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

DVA : 82.97 (-4.98%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

CNMD : 70.16 (-9.62%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Merit Medical Up 42.5% Since SmarTrend Uptrend Call (MMSI)

SmarTrend identified an Uptrend for Merit Medical (NASDAQ:MMSI) on March 26th, 2020 at $34.23. In approximately 5 months, Merit Medical has returned 42.50% as of today's recent price of $48.77.

MMSI : 40.55 (-3.89%)
OPKO Health's BioReference Laboratories Introduces NGS Assay

OPKO Health's (OPK) OnkoSight Advanced is a NGS assay that facilitates revolutionary DNA mutational profiling of tumor samples.

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
NXGN : 12.50 (-4.36%)
Merit Medical to Participate at Four Conferences in September

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology,...

MMSI : 40.55 (-3.89%)
Baxter (BAX) Attains FDA De Novo Authorization for Theranova

Baxter's (BAX) expanded HDx therapy delivered by Theranova becomes accessible for patients with kidney failure in the United States.

BAX : 80.10 (-3.46%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Masimo's (MASI) O3 Regional Oximetry Attains FDA Approval

Masimo's (MASI) O3 Regional Oximetry's FDA clearance can help clinicians offer quick and accurate care

MASI : 219.50 (-1.70%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Here's Why You Should Retain Inogen in Your Portfolio Now

Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
INGN : 27.84 (-3.23%)
Why Is Merit Medical (MMSI) Up 7.1% Since Last Earnings Report?

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MMSI : 40.55 (-3.89%)
Smith+Nephew Unveils Digital Platform to Boost Patient Care

With the help of the care management platform, Smith+Nephew (SNN) aims to help clinicians reduce the patient's post-acute recovery time.

SNN : 37.39 (-4.88%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Here's Why You Should Retain Luminex (LMNX) Stock for Now

Investor confidence is high on Luminex (LMNX) stock, thanks to solid prospects.

LMNX : 25.25 (-0.12%)
SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
OPK : 3.23 (+1.89%)
Merit Medical Shares Up 39.5% Since SmarTrend's Buy Recommendation (MMSI)

SmarTrend identified an Uptrend for Merit Medical (NASDAQ:MMSI) on March 26th, 2020 at $34.23. In approximately 5 months, Merit Medical has returned 39.52% as of today's recent price of $47.75.

MMSI : 40.55 (-3.89%)
Here's Why You Should Retain HMS Holdings in Your Portfolio

Investor confidence is high on HMS Holdings (HMSY) , thanks to solid prospects.

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
HMSY : 24.86 (-2.13%)
OPK : 3.23 (+1.89%)
The Zacks Analyst Blog Highlights: QIAGEN, Merit Medical, OPKO, Abbott and Abiomed

The Zacks Analyst Blog Highlights: QIAGEN, Merit Medical, OPKO, Abbott and Abiomed

ABMD : 260.03 (-1.90%)
MMSI : 40.55 (-3.89%)
QGEN : 49.47 (-2.21%)
ABT : 105.90 (-0.90%)
OPK : 3.23 (+1.89%)
Thermo Fisher Unveils Suite of Hematology-Oncology Solutions

The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from Thermo Fisher's (TMO) new portfolio of hematology-oncology solutions.

SRDX : 39.37 (-0.30%)
MMSI : 40.55 (-3.89%)
TMO : 418.84 (-2.38%)
OPK : 3.23 (+1.89%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar